Liver IDE deficiency is a risk factor for nonalcoholic fatty liver disease and prediabetes development

被引：0
|
作者：
Borges, D. O. [1 ,2 ]
Ribeiro, R. T. [3 ,4 ]
Penha-Goncalves, C. [5 ]
Macedo, M. P. [1 ,4 ]
机构：
[1] Chron Dis Res Ctr CEDOC, Metab Disorders Grp, Lisbon, Portugal
[2] Insituto Tecnol Quim & Biol Antonio Xavier ITQB N, Oeiras, Portugal
[3] APDP, Educ Res Ctr, Lisbon, Portugal
[4] Univ Aveiro, Dept Med Sci, Aveiro, Portugal
[5] Inst Gulbenkian Ciencias, Genet Dis Lab, Oeiras, Portugal
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
630
引用
收藏
页码：S302 / S303
页数：2
相关论文
共 50 条
  • [21] Subclinical Hypothyroidism as a Risk Factor for the Development of Cardiovascular Disease in Obese Adolescents With Nonalcoholic Fatty Liver Disease
    Sert, Ahmet
    Pirgon, Ozgur
    Aypar, Ebru
    Yilmaz, Hakan
    Odabas, Dursun
    PEDIATRIC CARDIOLOGY, 2013, 34 (05) : 1166 - 1174
  • [22] INCREASED RISK OF NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH GROWTH HORMONE DEFICIENCY
    Lee, Hye Won
    Hwang, Yoon A.
    Lee, Jae Seung
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Lee, Eun Jig
    Ku, Cheol Ryong
    Kim, Seung Up
    HEPATOLOGY, 2022, 76 : S626 - S626
  • [23] Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults with Prediabetes
    Phuc Le
    Chaitoff, Alexander
    Rothberg, Michael B.
    Alkhouri, Naim
    McCullough, Arthur
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2019, 34 (11) : 2336 - 2338
  • [24] Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults with Prediabetes
    Phuc Le
    Alexander Chaitoff
    Michael B. Rothberg
    Naim Alkhouri
    Arthur McCullough
    Journal of General Internal Medicine, 2019, 34 : 2336 - 2338
  • [25] Lumican in Obese Patients with Nonalcoholic Fatty Liver Disease With or Without Prediabetes
    Karamfilova, Vera
    Gateva, Antoaneta
    Assyov, Yavor
    Nedeva, Iveta
    Velikova, Tsvetelina
    Cherkezov, Nikolay
    Mateva, Ludmila
    Kamenov, Zdravko
    METABOLIC SYNDROME AND RELATED DISORDERS, 2020, 18 (09) : 443 - 448
  • [26] CHEMERIN IN OBESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE WITH OR WITHOUT PREDIABETES
    Karamfilova, Vera
    Nedeva, Iveta
    Assyov, Yavor
    Gateva, Antoaneta
    Velikova, Tsvetelina
    Cherkezov, Nikolay
    Mateva, Ludmila
    Kamenov, Zdravko
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2024, 77 (01): : 127 - 136
  • [27] Nonalcoholic fatty liver disease and cardiovascular risk
    Misra V.L.
    Khashab M.
    Chalasani N.
    Current Gastroenterology Reports, 2009, 11 (1) : 50 - 55
  • [28] Nonalcoholic fatty liver disease and cardiovascular risk
    Sciacqua, A.
    Perticone, M.
    Perticone, F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 15 - 15
  • [29] Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Azuma, Seishin
    Asahina, Yasuhiro
    Kakinuma, Sei
    Azuma, Keiko
    Miyoshi, Masato
    Inoue, Emi
    Tsunoda, Tomoyuki
    Sato, Ayako
    Kaneko, Shun
    Nagata, Hiroko
    Kawai-Kitahata, Fukiko
    Murakawa, Miyako
    Nitta, Sayuri
    Itsui, Yasuhiro
    Tomita, Makoto
    Nakagawa, Mina
    Watanabe, Mamoru
    DIGESTIVE DISEASES, 2019, 37 (03) : 247 - 254
  • [30] Risk factors in nonalcoholic fatty liver disease
    Ko, Eunji
    Yoon, Eileen L.
    Jun, Dae Won
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 : S79 - S85
12345